HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 380,
"next": "http://api.gregory-ms.com/trials/source/12/?page=2",
"previous": null,
"results": [
{
"title": "Lifestyle Intervention for Patients With Multiple Sclerosis",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Intervention</b>: Behavioral: Lifestyle intervention program \"Leef! met MS\"<br /><b>Sponsors</b>: Amsterdam UMC, location VUmc; National MS Foundation, The Netherlands; Voeding Leeft<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05402501?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-06-02T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-06-02T14:30:06.868908Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Aerobic Exercise in Persons With Multiple Sclerosis With Restless Legs Syndrome",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Intervention</b>: Behavioral: Aerobic exercise<br /><b>Sponsor</b>: Dokuz Eylul University<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05402956?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-06-02T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-06-02T14:30:06.875405Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Reinventing Yourself With Multiple Sclerosis (MS)",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Behavioral: Reinvention with MS<br/><b>Sponsors</b>: Kessler Foundation; Craig Hospital; University of Minnesota<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05195320?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-01-17T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-01-18T12:46:55Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "L Test in Multiple Sclerosis",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Intervention</b>: Behavioral: L test<br /><b>Sponsor</b>: Firat University<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05325359?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-13T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-13T11:59:18.442353Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Intervention</b>: Other: cytof analysis<br /><b>Sponsor</b>: Rennes University Hospital<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05326048?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-13T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-13T11:59:18.443892Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Effects of Telerehabilitation-Based Motor Imagery Training on Pain in People With Multiple Sclerosis",
"summary": "<b>Conditions</b>: Multiple Sclerosis; Pain<br /><b>Intervention</b>: Behavioral: Telerehabilitation-based motor imagery training<br /><b>Sponsors</b>: Dokuz Eylul University; Izmir Katip Celebi University<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05326711?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-13T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-13T11:59:18.445167Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "The Relationship of Neuropathic Pain With Incontinence, Disability and Life Quality in Multiple Sclerosis Patients",
"summary": "<b>Conditions</b>: Multiple Sclerosis; Disabilities Multiple; Quality of Life; Incontinence, Urinary; Incontinence Bowel; Neuropathic Pain<br /><b>Intervention</b>: Other: Neuropathic Pain<br /><b>Sponsor</b>: Istanbul University-Cerrahpasa<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05374811?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-05-16T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-05-16T12:00:08.079361Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "A Phase I Study of LP-168 in Healthy Volunteers",
"summary": "<b>Conditions</b>: Multiple Sclerosis; NMO Spectrum Disorder<br /><b>Interventions</b>: Drug: LP-168 tablet; Drug: LP-168 Placebo tablet<br /><b>Sponsor</b>: Guangzhou Lupeng Pharmaceutical Company LTD.<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05432713?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-06-27T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-06-27T13:30:06.503597Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Therapeutic Effects of Line Dancing in People With MS",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Intervention</b>: Other: line dancing<br /><b>Sponsors</b>: Gazi University; Hacettepe University; Fenerbahce University<br /><b>Completed</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05322915?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-12T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-12T12:59:17.118072Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf",
"summary": "<b>Condition</b>: Relapsing Multiple Sclerosis<br/><b>Interventions</b>: Other: Ofatumumab; Other: Ocrelizumab<br/><b>Sponsor</b>: Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05266469?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-03-04T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-03-04T17:22:45Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
}
]
}